Boehringer Ingelheim is announcing the launch of the 2026 Cardiovascular, Renal, Metabolic (CRM) Research Grant Program. Researchers and institutions are invited to submit applications for this prestigious grant opportunity, which supports innovative work in the fields of cardiovascular, renal, and metabolic health.
To learn more about the program details and application process, please review the RFP.
All applications must be submitted by March 23, 2026 for consideration.Access the application portal here.